UNDERSTANDING OPIOID OVERDOSE RISK IN A COMMERCIALLY INSURED POPULATION

被引：0
|
作者：
Halim, L. [1 ]
Shah, J. [1 ]
Bretzke, D. [1 ]
Needs, P. [1 ]
Couto, J. [1 ]
机构：
[1] Cigna Co, Bloomfield, CT USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH6
引用
收藏
页码：A292 / A292
页数：1
相关论文
共 50 条
  • [1] Patterns of Prescription Opioid Utilization Prior to Opioid Overdose in a Commercially Insured Population
    Dejene, Sara Z.
    Rough, Kathryn
    Huybrechts, Krista F.
    Hernandez-Diaz, Sonia
    Levin, Raisa
    Desai, Rishi J.
    Patorno, Elisabetta
    Bateman, Brian T.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 493 - 494
  • [2] Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose
    Follman, Sarah
    Arora, Vineet M.
    Lyttle, Chris
    Moore, P. Quincy
    Pho, Mai T.
    [J]. JAMA NETWORK OPEN, 2019, 2 (05)
  • [3] Opioid prescribing patterns in a commercially insured population
    Sera, Leah
    Lipphardt, Sarah
    Poling, Julie
    McGovern, Steve
    Cooke, Catherine E.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2022, 236
  • [4] Validation of an algorithm to identify opioid overdose among US commercially insured individuals
    Beachler, Daniel C.
    Zhou, Siting
    Gangemi, Kelsey
    Lanes, Stephan
    Walker, Alexander M.
    Rodriguez, Rachelle
    Coplan, Paul
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 130 - 130
  • [5] Opioid prescribing history prior to heroin overdose among commercially insured adults
    Lagisetty, Pooja
    Zhang, Kun
    Haffajee, Rebecca L.
    Lin, Lewei Allison
    Goldstick, Jason
    Brownlee, Rebecca
    Bohnert, Amy
    Larochelle, Marc R.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2020, 212
  • [6] COST OF OPIOID USE IN A COMMERCIALLY INSURED POPULATION OF FIBROMYALGIA PATIENTS
    Juday, T.
    Blum, S.
    Erder, M. H.
    [J]. VALUE IN HEALTH, 2009, 12 (03) : A134 - A135
  • [7] Incidence of Treatment for Opioid Use Disorder Following Nonfatal Overdose in Commercially Insured Patients
    Kilaru, Austin S.
    Xiong, Aria
    Lowenstein, Margaret
    Meisel, Zachary F.
    Perrone, Jeanmarie
    Khatri, Utsha
    Mitra, Nandita
    Delgado, Kit
    [J]. JAMA NETWORK OPEN, 2020, 3 (05)
  • [8] Drivers of Excess Costs of Opioid Abuse Among a Commercially Insured Population
    Scarpati, Lauren M.
    Kirson, Noam Y.
    Zichlin, Miriam L.
    Jia, Zitong B.
    Birnbaum, Howard G.
    Howard, Jaren C.
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2017, 23 (05): : 276 - U102
  • [9] Risk Factors for Serious Prescription Opioid-Induced Respiratory Depression or Overdose: Comparison of Commercially Insured and Veterans Health Affairs Populations
    Nadpara, Pramit A.
    Joyce, Andrew R.
    Murrelle, E. Lenn
    Carroll, Nathan W.
    Carroll, Norman V.
    Barnard, Marie
    Zedler, Barbara K.
    [J]. PAIN MEDICINE, 2018, 19 (01) : 79 - 96
  • [10] Opioid Use in the Management of Diabetic Peripheral Neuropathy (DPN) in a Large Commercially Insured Population
    Patil, Pravinkumar R.
    Wolfe, Jonathan
    Said, Qayyim
    Thomas, Jeremy
    Martin, Bradley C.
    [J]. CLINICAL JOURNAL OF PAIN, 2015, 31 (05): : 414 - 424
12345